Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management

Abstract

Molecular docking is a computational technique that predicts the binding affinity of ligands to receptor proteins. Although it has potential uses in nutraceutical research, it has developed into a formidable tool for drug development. Bioactive substances called nutraceuticals are present in food sources and can be used in the management of diseases. Finding their molecular targets can help in the creation of disease-specific new therapies. The purpose of this review was to explore molecular docking's application to the study of dietary supplements and disease management. First, an overview of the fundamentals of molecular docking and the various software tools available for docking was presented. The limitations and difficulties of using molecular docking in nutraceutical research are also covered, including the reliability of scoring functions and the requirement for experimental validation. Additionally, there was a focus on the identification of molecular targets for nutraceuticals in numerous disease models, including those for sickle cell disease, cancer, cardiovascular, gut, reproductive, and neurodegenerative disorders. We further highlighted biochemistry pathways and models from recent studies that have revealed molecular mechanisms to pinpoint new nutraceuticals' effects on disease pathogenesis. It is convincingly true that molecular docking is a useful tool for identifying the molecular targets of nutraceuticals in the management of diseases. It may offer information about how nutraceuticals work and support the creation of new therapeutics. Therefore, molecular docking has a bright future in nutraceutical research and has a lot of potentials to lead to the creation of brand-new medicines for the treatment of disease.

The effect of Cu(II) ion on antioxidant and DNA‐binding mechanism of baicalein and scutellarein: Spectroscopic, theoretical, and molecular docking study

“…Molecular docking represents a structure‐based drug design method that gained its popularity due to ease of access and low computational cost, which, however, comes at the cost of lower accuracy 77,78 . Its two principal steps include the prediction of the ligand conformation within the active site cavity (binding pose) and the evaluation of pose quality by calculation of the free binding energy (docking score) 79,80 . Throughout the years, molecular docking has been successfully used for high‐throughput virtual screenings of small ligands, 81 docking of protein–protein pairs, 82 modeling ligand‐DNA intercalations, 83 and assisting X‐ray crystallography in the fitting of substrates and inhibitors to electron density 79 .…”

Accurate Characterization of Binding Kinetics and Allosteric Mechanisms for the HSP90 Chaperone Inhibitors Using AI-Augmented Integrative Biophysical Studies

“…To comprehensively evaluate the predictive accuracy of models constructed with different features and apply them to the development of novel N-HSP90α inhibitors, we employed a strategy that combines docking-based affinity screening with binding kinetics screening to identify potential small molecule inhibitors. Molecular docking is a computational technique to predict the binding mode and binding affinity of ligand and receptor proteins, which is widely used in drug discovery and design. − The screening process is succinctly outlined in Figure . Initially, structures of N-HSP90α residues 104–114 with four distinct conformations (PDB IDs: 5J2X, 1YC1, 2XHX, and 5LQ9) were optimized using the Protein Preparation module in the Maestro software (Schrödinger, 2023).…”

Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence

“…230 For instance, molecular docking and binding mode analysis have shown that these methods can make small molecules that are more active than those in the crystal structure and have similar places where they can interact with ligands. 232 Pharmaceutical chemists may obtain novel concepts and recommendations from this, which could expedite the process of developing innovative inhibitors and drugs. 233 The ligand-based drug design covering library preparation, compound representation, and SAR analysis to molecular generation is discussed in Figure 3.…”

“…These DL-based molecular generation techniques can also help identify protein-active sites . For instance, molecular docking and binding mode analysis have shown that these methods can make small molecules that are more active than those in the crystal structure and have similar places where they can interact with ligands . Pharmaceutical chemists may obtain novel concepts and recommendations from this, which could expedite the process of developing innovative inhibitors and drugs .…”